HighTide Therapeutics Funding: $167M Raised, Series C (2020)
HighTide Therapeutics is based in Shenzhen, China. It has raised $167M in total funding. Latest round: Series C.
HighTide Therapeutics funding overview
HighTide Therapeutics is based in Shenzhen, China. HighTide Therapeutics has raised $167M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series C announced in December 2020. The round record for HighTide Therapeutics runs through 2020; nothing later has been disclosed.
HighTide Therapeutics at a glance
Total raised
$167M
Latest round
Series C
Latest round date
December 2020
Headquarters
Shenzhen, China
Frequently asked about HighTide Therapeutics funding
How much has HighTide Therapeutics raised?
HighTide Therapeutics has raised $167M in total disclosed funding across the rounds on record.
Who has invested in HighTide Therapeutics?
No investors are named on the public record for HighTide Therapeutics yet.
What was the latest HighTide Therapeutics funding round?
The most recent disclosed round is a Series C, announced in December 2020.
Where is HighTide Therapeutics based?
HighTide Therapeutics is based in Shenzhen, China.
When did HighTide Therapeutics last raise?
The last disclosed HighTide Therapeutics round closed in December 2020 at Series C.
Totals shown for HighTide Therapeutics aggregate every disclosed round on file. To see how that compares, browse the companies in Shenzhen and the investors behind them below.
